Publication:


abstract

Increased oxidative stress occurs in the lungs and systemically in COPD, which plays a role in many of the pathogenic mechanisms in COPD. Hence, targeting local lung and systemic oxidative stress with agents that modulate the Antioxidants/redox system or boost endogenous antioxidants would be a useful therapeutic approach in COPD. Thiol antioxidants (N-acetyl-l-cysteine [NAC] and N-acystelyn, carbocysteine, erdosteine, and fudosteine) have been used to increase lung thiol content. Modulation of cigarette smoke (CS) induced oxidative stress and its consequent cellular changes have also been reported to be effected by synthetic molecules, such as spin traps (α-phenyl-N-tert-butyl nitrone), catalytic antioxidants (superoxide dismutase [ECSOD] mimetics), porphyrins, and lipid peroxidation and protein carbonylation blockers/inhibitors (edaravone and lazaroids/tirilazad). Preclinical and clinical trials have shown that these antioxidants can reduce oxidative stress, affect redox and glutathione biosynthesis genes, and proinflammatory gene expression. In this review the approaches to enhance lung antioxidants in COPD and the potential beneficial effects of antioxidant therapy on the course of the disease are discussed.

Copyright © 2012. Published by Elsevier Ltd.

Related Articles
Pharmacological antioxidant strategies as therapeutic interventions for COPD.
Biochim Biophys Acta. 2012
Pharmacological antioxidant strategies as therapeutic interventions for COPD.
Rahman I. Biochim Biophys Acta. 2012 May; 1822(5):714-28. Epub 2011 Nov 9.
Review Antioxidant therapies in COPD.
Int J Chron Obstruct Pulmon Di...
Review Antioxidant therapies in COPD.
Rahman I. Int J Chron Obstruct Pulmon Dis. 2006; 1(1):15-29.
Review Antioxidant therapeutic advances in COPD.
Ther Adv Respir Dis. 2008
Review Antioxidant therapeutic advances in COPD.
Rahman I. Ther Adv Respir Dis. 2008 Dec; 2(6):351-74.
Review Antioxidant therapeutic targets in COPD.
Curr Drug Targets. 2006
Review Antioxidant therapeutic targets in COPD.
Rahman I, Kilty I. Curr Drug Targets. 2006 Jun; 7(6):707-20.
Review Oxidative stress and redox regulation of lung inflammation in COPD.
Eur Respir J. 2006
Review Oxidative stress and redox regulation of lung inflammation in COPD.
Rahman I, Adcock IM. Eur Respir J. 2006 Jul; 28(1):219-42.